anti-fcrn monoclonal antibody imvt-1402
Generic: Anti-FcRn Monoclonal Antibody IMVT-1402
anti-fcrn monoclonal antibody imvt-1402: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Roivant Sciences Ltd. (ROIV) | Phase 2/Phase 3 |
Get deeper analysis on anti-fcrn monoclonal antibody imvt-1402
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis